trying not to respond to clinical emails on conference leave #EHA24

Great to catch up and share data as always! #EHA24 #lymSM

Curve is looking pretty good after 24 months… but agree longer follow up needed. In an elderly patient a late death from unrelated cause will still count as a PFS event… #lymSM #EHA24

why is every Pharma-arranged meeting now a "roundtable"?

this is my preferred format, yes!

At #EHA2024, we heard from Chan Cheah (Linear Clinical Research) on the role of covalent & non-covalent BTK inhibitors in the MCL treatment landscape. Watch the interview here: 🎥 ow.ly/tt7850SqK6L #MantleCellLymphoma #LYMsm #NonHodgkinLymphoma #Lymphoma European Hematology Association

Does anyone else get #TDFF2024 withdrawal on rest days? I might actually have to work this evening to pass the time!

Good news for follicular lymphoma patients: #epcoritamab receives positive conditional marketing approval from CHMP/EMA based on phase II NHL-1 study results. Another CD20 x CD3 bispecific antibody available ir.genmab.com/news-releases/… #lymSM

Just out in The Lancet Haematology Pirtobrutinib in Richter transformation n=82, 90% R/R 74% prior cBTKi ORR 50%, CR 13% well tolerated bridge to allo in 8 pts promising potential in difficult disease look out for a phase 3 RCT coming soon! #lymSM #CLLsm sciencedirect.com/science/articl…

Best thing about late July (besides Tour de France™) is getting hands on the abstracts for the ASH!

I was never a R-CHOEP user but I know some of you were Mark Hertzberg Jørgensen et al: MAIC of R‐CHOP vs R‐CHOEP for young pts w high‐risk DLBCL: Danish observational study onlinelibrary.wiley.com/doi/10.1111/ej… n=396 no difference in PFS or OS not an RCT but we will never see one... #lymSM

well deserved Katharine Lewis Women In Lymphoma - [email protected] is lucky to have you! #lymSM

Super work Jaimal Kothari this is an important study for the WM field. Always a special day seeing an IIT set sail #ClinicalTrials

Kudos Dr Emma Verner Judith Trotman on the publication of Australasian Leukaemia & Lymphoma Group (ALLG) NHL29 IRiC study of #Ibrutinib plus R-mini-CHOP in very elderly patients with newly diagnosed DLBCL Blood Advances great to see this out #lymSM ashpublications.org/bloodadvances/…

Really excited to share our review article on updates in the biology, prognostication and treatment of nodular lymphocyte predominant Hodgkin lymphoma. A massive thanks to Chan Cheah and Graham Collins for your guidance and support. doi.org/10.3324/haemat…

Great to see this out in Haematologica Kudos Ross Salvaris #lymSM